ArticleWorld journal of microbiology & biotechnology2025
Production of the terpenoid-based biofuel α-bisabolene by metabolically engineered Corynebacterium glutamicum.
Article in World journal of microbiology & biotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Engineering of Corynebacterium glutamicum for biosynthesis of the pharmaceutically active N-acetyltyramine: establishing and optimizing de novo production.Journal of biological engineering · 2026Article
- High-copy plasmid engineering enhances recombinant protein and antimicrobial peptide production in Corynebacterium glutamicum.Microbial cell factories · 2026Article
- Strategic selection of microbial cell factories for sustainable and application-specific terpenoid production.Frontiers in bioengineering and biotechnology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
The depletion of fossil resources and their detrimental impact on global climate change necessitate the development of sustainable, renewable alternatives. Advanced fuels derived from microbial fermentation represent a promising route towards reducing dependency on petroleum-derived energy sources. In this respect, terpenoids emerge as attractive candidates for biofuel applications. Among terpenoids, α-bisabolene, a plant-derived sesquiterpenoid, has attracted attention as a potential diesel substitute owing to its high energy density and favorable combustion properties. In this study, the biotechnologically well-established Gram-positive bacterium Corynebacterium glutamicum was metabolically engineered for the biosynthesis of α-bisabolene for the first time. C. glutamicum exhibited robust growth in the presence of up to 1 g/L exogenously added α-bisabolene, showing its suitability as a host for α-bisabolene production. Among the different solvents for in situ product recovery, isopropyl myristate was identified as the most suitable to capture α-bisabolene, yielding 87.1 ± 7.1 mg/L. To address the "food vs. fuel" debate, α-bisabolene biosynthesis was achieved on glycerol, arabinose, and xylose, offering further sustainability and cost-effectiveness. By overexpressing dxs and idi, the production was increased to 296.5 ± 15.9 mg/L. This study broadens the biofuel product spectrum of C. glutamicum and supports their production based on alternative carbon sources.
Indexed as
Identifiers
41099948What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.